Monitoring product integrity of a pharmaceutical product in a syringe using a miniaturized electronic sensor tag
10646640 ยท 2020-05-12
Assignee
Inventors
Cpc classification
A61M5/002
HUMAN NECESSITIES
A61J1/18
HUMAN NECESSITIES
A61M5/5086
HUMAN NECESSITIES
G06K19/07345
PHYSICS
A61M5/31511
HUMAN NECESSITIES
G06K19/07798
PHYSICS
G06K19/0717
PHYSICS
G06K19/07705
PHYSICS
A61M2205/6027
HUMAN NECESSITIES
International classification
A61M5/00
HUMAN NECESSITIES
A61M5/50
HUMAN NECESSITIES
A61J1/18
HUMAN NECESSITIES
A61M5/315
HUMAN NECESSITIES
G06K19/077
PHYSICS
Abstract
The package for a pharmaceutical product includes a syringe and an electronic tag for obtaining information relating to the integrity of the product as assessed from an exposure of said product to physical or environmental conditions during a time span. The tag is attached at or to a constituent of the syringe; or at least a portion of the tag is integrated in a constituent of the syringe. The tag includes an electronics unit having a control unit, a sensor unit having at least one sensor for monitoring the physical or environmental conditions, a display unit having a display for displaying data relating to the integrity referred to as status data and a switch. The control unit is structured and configured for effecting that the display unit displays the status data in reaction to an operation of the switch.
Claims
1. A package for a pharmaceutical product, said package comprising a syringe; an electronic tag for obtaining information relating to the integrity of the product as assessed from an exposure of said product to physical or environmental conditions during a time span; wherein said tag is attached at or to a constituent of said syringe; and said tag comprising a main part comprising an electronics unit comprising a control unit; a sensor unit comprising at least one sensor for monitoring said physical or environmental conditions; a display unit comprising a display for displaying data relating to said integrity referred to as status data; and wherein a foil bonded to said constituent of said syringe holds said main part between itself and said constituent of said syringe.
2. The package according to claim 1, wherein said constituent of said syringe is a plunger top.
3. The package according to claim 1, wherein said constituent of said syringe is a barrel of said syringe.
4. The package according to claim 1, wherein said constituent of said syringe is a constituent of a plunger arrangement of said syringe.
5. The package according to claim 1, wherein said foil is a polymer foil.
6. The package according to claim 1, wherein said main part is sandwiched between said foil and said constituent of said syringe.
7. The package according to claim 1, wherein the package comprises a pressing surface for operating said syringe by pressing against said pressing surface, and wherein said pressing surface is provided by said tag, and wherein said switch is structured and arranged in such a way that it is operated when pressure is exerted against said pressing surface for operating the syringe.
8. The package according to claim 1, wherein said foil is bonded to said constituent of said syringe via a bonding material.
9. The package according to claim 1, wherein said foil is bonded to said constituent of said syringe in an area partially surrounding said main part.
10. The package according to claim 1, wherein said display unit comprises one or more light emitters for emitting light pulses, and wherein said status data is encoded in a sequence of light pulses emitted by said one or more light emitters.
11. A packaged pharmaceutical product, comprising a package according to claim 1 and said pharmaceutical product, wherein said pharmaceutical product is contained in said syringe.
12. A method for manufacturing a package for a pharmaceutical product, the method comprising the steps of A) providing at least one constituent of a syringe for applying said pharmaceutical product; B) providing an electronic tag for obtaining information relating to the integrity of said product as assessed from an exposure of said product to physical or environmental conditions during a time span; the method further comprising the step of C) attaching said tag to said at least one constituent of said syringe; wherein said electronic tag comprises a main part and step C) comprises bonding a foil to said at least one constituent of said syringe to hold said main part between itself and said at least on constituent of said syringe.
13. A method according to claim 12, wherein step C) comprises sandwiching said main part between said foil and said at least one constituent of said syringe.
14. A method for monitoring an integrity of a pharmaceutical product, the method comprising the steps of a) providing a syringe; b) providing an electronic tag attached at or to a constituent of said syringe, said syringe comprising a barrel, said barrel containing said pharmaceutical product; said tag being a tag for obtaining information relating to the integrity of said product as assessed from an exposure of said product to physical or environmental conditions during a time span, the tag comprising a main part comprising an electronics unit comprising a control unit; a sensor unit comprising at least one sensor for monitoring said physical or environmental conditions; a display unit comprising a display for displaying data relating to said integrity referred to as status data; wherein a foil bonded to said constituent of said syringe holds said main part between itself and said constituent of said syringe.
15. The method according to claim 14, wherein said constituent of said syringe is a barrel of said syringe or is a constituent of a plunger arrangement of said syringe.
Description
BRIEF DESCRIPTION OF THE DRAWINGS
(1) Below, the invention is described in more detail by means of examples and the included drawings. The figures show schematically:
(2)
(3)
(4)
(5)
(6)
(7)
(8)
(9)
(10)
(11)
(12)
(13)
(14)
(15)
(16)
(17)
(18)
(19)
(20)
(21)
DETAILED DESCRIPTION OF THE INVENTION
(22) The described embodiments are meant as examples and shall not limit the invention.
(23)
(24) Tag 1 of
(25) The main part 2 includes an electronics unit including i.a. a user-operable switch 9 (cf. the dotted hand symbol in
(26) In fact, the electronics unit (having reference symbol 40 in further figures) and the rip strip 3 may be considered to share one printed circuit board. And the electronics unit 40 may be considered to be a printed circuit board assembly (PCB assembly or PCBA), i.e. a PCB with components mounted thereon (the components being described above and also below), wherein the PCB forming the rip strip 3 is continuous with the PCB of the PCBA representing the electronics unit 40.
(27)
(28) Tag 1 includes electronics unit 40 in its main part 2 and rip strip 3, each including a portion of one and the same PCB, which may be a flexible PCB.
(29) Tag 1 and, more particularly, main part 2 includes a housing 41 in which electronics unit 40 is present. Electronics unit 40 includes, besides the PCB and mounted thereon, an energy source such as a battery 42, the above-mentioned switch 9, which may be, e.g., an electro-mechanical switch or a capacitive switch, the light emitters of the display (only LED 7 being illustrated in
(30) It is possible that data sensed by a sensor of the sensing unit are continuously (or quasi-continuously) taken, but usually, measuring or sensing takes place in time intervals of between 30 seconds and 12 hours, more particularly between 1 minute and 30 minutes, so as to save energy.
(31) Housing 41 may be made substantially of a material which is sufficiently transparent for letting light emitted by light emitters 7, 8 of tag 1 pass through such that it is visible from the outside, or may include, as indicated in
(32) In order to attach tag 1 to a tag carrier 11 such as a constituent of a syringe, e.g., a plunger top, a double-faced adhesive tape 15 may be used. An alternative would be to use a different bonding technique such as the application of an initially liquid bonding material such as a glue. A bonding may take place between the housing 41 and the tag carrier 11, and it is possible, as indicated in
(33) An alternative way of attaching tag 1 to a tag carrier 11 is illustrated in
(34) Suitable tag carriers 11 are constituents of a syringe to be provided with a tag, e.g., the barrel of the syringe or a constituent of the plunger arrangement of the syringe. Below, a plunger top will be described as a possible tag carrier, but also a barrel of a syringe will be described as a possible tag carrier.
(35) A pharmaceutical product (later referenced by reference numeral 24) to be monitored by means of the tag is contained in the syringe, more particularly in a barrel of the syringe. The pharmaceutical product usually will be provided in liquid form, so as to be injectable using the syringe.
(36)
(37) Syringe 70 is contained in a blister-type package 22 usually made of a polymer (and possible also paper-type material) which again is contained in a box 12, which typically is a folding carton. Instead of such a two-level package 10, also a single-level package might be used for packaging product 24, e.g., providing box 12 only (and no blister-type bag) and providing a blister-type package 22 only (and no additional box).
(38) Whatever constitutes the outer-most package level (in
(39) It is to be noted that it is possible that inside a package, e.g., inside a folding carton or a blister-type package, two or more parts (or constituents) of the syringe are separate, i.e. disassembled. In particular, the plunger top (including the tag) and the plunger rod (or a portion of the plunger rod) may be one part which is separate from another part which establishes the barrel and the plunger seal (and possibly also a portion of the plunger rod). Before use, the syringe then has to be assembled from the separate parts.
(40) Providing a disassembled syringe can allow to package the syringe (including the tag) in a smaller outer package, e.g., a smaller folding carton. And an accidental pressing of the pharmaceutical product out of the barrel may be largely inhibited.
(41) A tag 1, e.g., a tag like described elsewhere in the present patent application, e.g., in
(42) Bag 22 is a container which usually is at least partially constituted by a polymer foil, in particular by transparent polymer foil.
(43) A tag 1, e.g., one as described above, and, more particularly, the corresponding electronics unit 40 can be structured and configured for detecting an interruption of a conductor line loop of rip strip 3, e.g., by cutting rip strip 3 using a cutting tool or by ripping rip strip 3 by hand. And, moreover, this may result in a termination of the monitoring (and of the measurements and of the sensing) being accomplished (or at least evaluated) by the tag 1.
(44) Accordingly, it can be provided that monitoring the integrity of a product 24 is carried out from a starting event to an end point. The starting event can be, e.g., when syringe 70 is packaged in an outer package (in particular into a folding box), or when syringe 70 is assembled (with product 24 in barrel 72), or when product 24 is filled into barrel 72. The end point may be indicated by a ripping of rip strip 3. And this ripping can be linked to an accessing of product 24, e.g., by prescribing (to a user such as a patient or a health care specialist) that rip strip 3 has to be ripped when box 12 is opened or when the syringe is about to be used (for giving a shot). This way, it can be ensured to some extent that the monitoring of the integrity of product 24 is terminated when product 24 is accessed. The integrity status of product 24 may, also in reaction to the ripping, be stored in tag 1 such that it can be recalled later (namely by operating switch 9, cf.
(45) A beginning of the time span during which the physical or environmental conditions are monitored may be indicted by breaking another loop present on rip strip 3, cf. also
(46) Alternatively, the monitoring can be started differently, cf. below at the description of
(47) As is clear from the above, a display 6 of a tag 1 may include (an in particular essentially consist of) one or more light emitters such as LEDs, in particular light emitters of different color, e.g., one emitting red light and another emitting green light. A control unit of tag 1, e.g., an integrated circuit, e.g., the one of
(48) Assuming that in addition, the duration (of a pulse in a sequence) is a parameters which can be varied for displaying integrity status information, it can be provided, e.g., that two or more types of alarm (or types of failures) are indicated by different pulse durations. An example will be illustrated and described by means of
(49)
(50) One way of distinguishing three types of failures (one, two or three of which may have occurred and thus may have to be indicated when displaying the integrity status) works as follows:
(51) If a failure of a first type has occurred, a single short red pulse is emitted (cf. curve a).
(52) If a failure of a second type has occurred, a two short red pulses are emitted (cf. curve b).
(53) If failures of both, first and second type, have occurred, a three short red pulses are emitted (cf. curve c).
(54) If a failure of a third type has occurred, a single long red pulse is emitted (cf. curve d).
(55) If, in addition to a failure of the third type, a failure of the first and/or a failure of the second type has occurred, the (partial) sequence for the additional failure(s) is appended to the long red light pulse indicating the third type failure. Curve e indicates the case that a failure of a first type and a failure of a third type have occurred.
(56) A failure of first type may mean, e.g., that an upper temperature limit T(up) has been exceeded.
(57) A failure of second type may mean, e.g., that a lower temperature limit T(low) has been fallen short of
(58) A failure of third type may mean, e.g., that a threshold temperature limit T(thr) has been exceeded (or fallen short of) for a too long time, more particularly for more than a prescribed threshold time t(thr).
(59) Such a kind of data indicative of prescribed limitations of a product, e.g., T(up), T(low), T(thr) and t(thr), are usually stored in the electronics unit. They may be programmable in a way described further above in the present patent application. If programming pads are provided for programming such values, these may in particular be provided on the rip strip.
(60)
(61) In the process of packaging pharmaceutical products, a (high) number of such tags 1 may be present, and an arbitrary one of them is selected for the next product, and thenwhen the type of product to be packaged is knownthe data indicative of prescribed limitations of that specific product for the exposure of that specific product to the monitored physical or environmental conditions are programmed (using pads 60 and 66). This way, in a single packaging line, the provision of a single type of tag 1 can be sufficient for packaging (and monitoring) in that packaging line a plurality of different products (with different prescribed limitations). Accordingly, storing various different types of tags, each specifically designed for the different products to be packaged (set to the respective specific prescribed limitations for the exposure of the product to the physical or environmental conditions), may become superfluous this way.
(62) And starting the monitoring by opening loop L2, e.g., by cutting along line s2, will simultaneously make a reprogramming of tag 1 difficult, thus impeding tampering with the tag.
(63) If product integrity is in order, this may be indicated by one or more green light pulses. It is, more specifically, possible to distinguish different types of (still-)in-order statuses. For example, in a first case, a single green pulse is emitted, cf., e.g., curve a or curve e. And in a second case, two green pulses are emitted, cf., e.g., curve b, or more than two pulses are emitted, or green and red pulses are emitted.
(64) The first (still-)in-order status case may be, e.g., that no threshold value has been reached. In case a temperature is monitored, this would be the case, e.g., if the temperature never left the range at which the product may be kept virtually forever or (as more often will be the case) until its expiration date.
(65) The second (still-)in-order status case may be, e.g., that for more than a pre-selected time duration, a threshold value has been exceeded and fallen short of, respectively, (depending on the threshold being an upper and a lower threshold value, respectively). For example, in case a temperature is monitored, this would be the case, e.g., if the temperature of the product may be above an upper threshold of, e.g., 37 C. for at most, e.g., 72 hours, and an alarm is desired as soon as only 24 hours or less are left (24 hours being the pre-selected time duration). If then the temperature has in fact been above 37 C. for already more than 48 hours, such that the product will be in order for only less than 24 hours (provided that its temperature will remain above 37 C.), the second (still-)in-order status shall be indicated.
(66)
(67) Interrupting another electrical contact (cf. step 140) results in terminating the time span and the monitoring (step 150), obtaining the final status data (step 160) and displaying the final status data (step 170). When later on, switch 9 is operated (step 180), the final status data are displayed (step 190).
(68) It is to be noted that usually, the status data will not be permanently displayed, but only when the switch 9 is operated; and optionally also when the time span (and thus the monitoring) is terminated and/or optionally in (regular) time intervals (controlled by the control unit), the time intervals being usually between 1 second and 2 minutes, more particularly between 10 seconds and 1 minute.
(69)
(70) Otherwise, the method and the corresponding package and tag may be as described elsewhere herein.
(71) Note that the initiating switch may in particular be a magnetic or inductive switch. For example, the manufacturing of the retail package or retail unit may include moving the same along a path along which a suitable magnet (permanent or electromagnet) and a suitable coil, respectively, is suitably positioned, e.g., along a path described by a conveyor transporting the retail package or retail unit. Then, while passing along the respective magnetic or electric field, the initiating switch is operated (without mechanically contacting the tag), and the monitoring starts. However, the initiating switch might also be an electro-mechanical or a capacitive switch, the latter also allowing a contact-free operation.
(72) Of course, it is also possible to provide in the embodiment of
(73) Instead of bonding the tag 1 to a part of the syringe 70, tag 1 can be attached thereto in a different manner or even be integrated, at least in part, therein. The following examples basically refer to the plunger top as a syringe constituent to or at which the tag is attached or in which a part of the tag, such as in particular a housing of the tag, is integrated. But other constituents of the syringe may also be used for attaching or integrating the tag.
(74)
(75) PCB 34 of tag 1 is present between battery 42 and the electronic components of tag 1.
(76) In order to be able to insert electronics unit 40 into housing 41, the latter may be dividable into two (or possibly more) parts, e.g., along the dotted line in
(77) Plunger rod 78 may be fixed to plunger top 77, e.g., by a threading (not illustrated in
(78) However, plunger rod 78 may alternatively be integrally formed with plunger top 77, e.g., the two being a single injection molded part. In this case, for assembling housing 41 and the plunger top/plunge rod part, the lower half of housing 41 (which has the above-mentioned hole) may be pushed over the plunger rod, with the hole, from the free end of plunger rod 78. With the two housing halves still separate, electronics unit 40 can be inserted into housing 41, and then, housing 41 can be closed, which in addition attaches tag 1 to plunger top 77.
(79)
(80) The housing 41 of
(81) The housing in
(82)
(83)
(84)
(85)
(86)
(87)
(88) First housing portion 45 provides two transparent portions which may be windows (in particular be having a reduced thickness) or openings (not drawn in
(89) In addition, housing 41 provides a flexible portion 38 which is defined by a slit in housing 41. A switch of an electronics unit to be inserted into housing 41 can be more easily approached this way. Pushing the flexible portion 38 from outside housing 41 can allow to readily operate a switch positioned below the flexible portion 38.
(90) The two housing portions 45, 46 can be designed to establish a snap fit. This way, housing 41 can be readily closed (after inserting the electronics unit), and a well-defined alignment of the housing parts can be achieved this way.
(91)
(92) Housing 41 includes another opening, referenced 37, through which a rip strip (if present in the tag) may extend out of housing 41.
(93) Furthermore, housing 41 provides a holder or fixture for a constituent of the tag, in particular for a battery of the tag. For establishing this, e.g., protrusions 39 like illustrated in
(94)
(95)
(96) However, the assembly of
(97)
(98) Electronics unit 40 and its constituents are well visible in
(99) At flexible portion 38, a protrusion 38a may be provided which facilitates operating switch 9 (with housing 41 closed).
(100)
(101) A battery contact lead 33 contacting battery 42 is visible in
(102) Described arrangements of the tag and the switch at the plunger top allow to make sure that a person about to use (operate) the syringe will, practically inevitably, effect a display of the integrity status. Pressing against the plunger top or a portion of the tag present there for pressing some of the pharmaceutical product or air present in the syringe out of the syringe can result in operating the switch (display switch), such that the integrity status is displayed. In case the display indicates that the pharmaceutical product has been exposed to detrimental conditions, an injection of (probably) perished medication can be avoided.
(103) The tag, the package and the packaged pharmaceutical product described in the present patent application are easy to use and operable by untrained personnel, i.e. by people not specifically instructed on how to use the tag, the package, the packaged pharmaceutical product, as far as the integrity monitoring is concerned. Patients and health care specialists who apply or use the pharmaceutical product can, without additional measures and without the need of additional tools, check the integrity of the product to be applied or used. And this can be accomplished (at least approximately) at the time when the product is applied or used. Suitably positioning the tag and in particular the (display) switch can make a display of status data (practically) unavoidable at the time the syringe (and the pharmaceutical product) is about to be used, cf. above.
(104) It can happen that pharmaceutical products are returned from the acquirer or user (e.g., patient or health care specialist) to the manufacturer or the distributor without having been used. This sometimes is the case, e.g., in case of particularly valuable products.
(105) If the product is returned to the manufacturer or distributor, the manufacturer or distributor can check the integrity status of the product by using the tag. Based thereon, it can, e.g., be decided whether or not to forward the product to another acquirer or user.
(106) Independently of having checked the integrity status or not, it may be provided that the manufacturer or distributor forwards the product to another acquirer or user. That other acquirer or user can then (e.g., when the product is about to be applied) check the integrity status of the product using the herein described tag and the package, respectively.
(107) It shall be noted that the tag, the package and the packaged pharmaceutical product provide standalone solutions which do not require further equipment, at least not for having the integrity status of the product displayed. And the attaching of the tag to the syringe can be accomplished by the manufacturer or by the packaging company packaging the product in a box.
(108) The tag may consist of merely:
(109) an electronics unit; and
(110) a PCB (typically a flexible PCB) forming, if present, the rip strip, and the PCB on which the components of the electronics unit are mounted; wherein the electronics unit may consist merely of:
(111) a switch (and possibly also a second switchnamely, e.g., for starting the monitoring);
(112) one or more, typically two, light emitters, typically LEDs;
(113) an integrated circuit (embodying at least the control unit); and
(114) an energy source such as a battery;
(115) wherein, if the one or more sensors are not integrated in the integrated circuit, at least one sensor is, in addition, comprised, too, in the electronics unit, and
(116) wherein optionally up to four capacitors and/or up to four resistors may be comprised, too, in the electronics unit. And typically, all components comprised in the electronics unit are mounted on the PCB, more precisely on one and the same PCB.
(117) Note that the PCB can be sufficient for electrically contacting the energy source (battery), cf.
(118) And note furthermore, that it is possible that the rip strip is dispensed with (at least in its function as providing a means for starting the monitoring) and/or the switch may be dispensed with (at least in its function as a means for requesting a displaying of the status data, and this at least for times not coinciding with the time of terminating the monitoring).
(119) A display of an above-described kind can be particularly small and cost-efficient. There is no need for a liquid crystal display or the like.